Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Program
-
Field
-
tissue. As the successful candidate you will have a PhD in instrument development or be due to complete doctoral studies within 6 months of applying. Ideally you will have experience of light sheet imaging
-
at imaging entire tissues at sub-micron resolution and to develop tissue clearing methods suitable for live or fixed tissue. As the successful candidate you will have a PhD in instrument development or be due
-
Deciphering Streptococcus dysgalactiae subsp. equisimilis Population Genomics and Host-Pathogen Interactions using Advanced 3D Tissue Engineered Infection Models School of Biosciences PhD Research
-
: 2026-04-09 Where to apply Website https://academicpositions.com/ad/kth-royal-institute-of-technology/2026/postdoc… Requirements Research FieldBiological sciencesYears of Research Experience4 - 10
-
Expected Start Date: July – Sep 2025 Basic Qualifications A PhD in Bioengineering, Biomedical Engineering, Electrical Engineering, Mechanical Engineering, and/or Neuroscience Extensive experience with
-
biofabrication, contributing to advances in bone tissue engineering and developing expertise in additive manufacturing technologies and biomedical applications. Application Procedure To participate, you must
-
tomorrow. Where to apply Website https://academicpositions.com/ad/eth-zurich/2026/phd-position-computer-simulati… Requirements Research FieldEngineeringYears of Research Experience1 - 4 Research
-
KTH Royal Institute of Technology, School of Engineering Sciences in Chemistry, Biotechnology and Health Job description Tissue organization is achieved by the genome encoding both cell type
-
use proprietary micropattern technology and other tissue culture techniques to develop techniques to isolate, culture, and propagate adult and embryonic coral stem cells. Our lab places a strong
-
abnormal scarring of the liver in which healthy tissue is replaced by a rigid and dysfunctional extracellular matrix (ECM). It results from chronic damage, activating myofibroblasts, the main agents